Table of Content

1 Market Overview of GM1 Gangliosidosis Treatment
1.1 GM1 Gangliosidosis Treatment Market Overview
1.1.1 GM1 Gangliosidosis Treatment Product Scope
1.1.2 GM1 Gangliosidosis Treatment Market Status and Outlook
1.2 Global GM1 Gangliosidosis Treatment Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global GM1 Gangliosidosis Treatment Market Size by Region (2024-2034)
1.4 Global GM1 Gangliosidosis Treatment Historic Market Size by Region (2024-2024)
1.5 Global GM1 Gangliosidosis Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, GM1 Gangliosidosis Treatment Market Size (2024-2034)
1.6.1 North America GM1 Gangliosidosis Treatment Market Size (2024-2034)
1.6.2 Europe GM1 Gangliosidosis Treatment Market Size (2024-2034)
1.6.3 Asia-Pacific GM1 Gangliosidosis Treatment Market Size (2024-2034)
1.6.4 Latin America GM1 Gangliosidosis Treatment Market Size (2024-2034)
1.6.5 Middle East & Africa GM1 Gangliosidosis Treatment Market Size (2024-2034)
2 GM1 Gangliosidosis Treatment Market by Type
2.1 Introduction
2.1.1 LYS-GM101
2.1.2 PBGM01
2.1.3 AXO-AAV-GM1
2.2 Global GM1 Gangliosidosis Treatment Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global GM1 Gangliosidosis Treatment Historic Market Size by Type (2024-2024)
2.2.2 Global GM1 Gangliosidosis Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America GM1 Gangliosidosis Treatment Revenue Breakdown by Type (2024-2034)
2.3.2 Europe GM1 Gangliosidosis Treatment Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific GM1 Gangliosidosis Treatment Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America GM1 Gangliosidosis Treatment Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa GM1 Gangliosidosis Treatment Revenue Breakdown by Type (2024-2034)
3 GM1 Gangliosidosis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Type 1 GM1 Gangliosidosis
3.1.2 Type 2 GM1 Gangliosidosis
3.1.3 Type 3 GM1 Gangliosidosis
3.2 Global GM1 Gangliosidosis Treatment Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global GM1 Gangliosidosis Treatment Historic Market Size by Application (2024-2024)
3.2.2 Global GM1 Gangliosidosis Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America GM1 Gangliosidosis Treatment Revenue Breakdown by Application (2024-2034)
3.3.2 Europe GM1 Gangliosidosis Treatment Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific GM1 Gangliosidosis Treatment Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America GM1 Gangliosidosis Treatment Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa GM1 Gangliosidosis Treatment Revenue Breakdown by Application (2024-2034)
4 GM1 Gangliosidosis Treatment Competition Analysis by Players
4.1 Global GM1 Gangliosidosis Treatment Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GM1 Gangliosidosis Treatment as of 2022)
4.3 Date of Key Players Enter into GM1 Gangliosidosis Treatment Market
4.4 Global Top Players GM1 Gangliosidosis Treatment Headquarters and Area Served
4.5 Key Players GM1 Gangliosidosis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 GM1 Gangliosidosis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Axovant Gene Therapies Ltd
5.1.1 Axovant Gene Therapies Ltd Profile
5.1.2 Axovant Gene Therapies Ltd Main Business
5.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Products, Services and Solutions
5.1.4 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue (US$ Million) & (2024-2024)
5.1.5 Axovant Gene Therapies Ltd Recent Developments
5.2 Passage Bio and Lysogene
5.2.1 Passage Bio and Lysogene Profile
5.2.2 Passage Bio and Lysogene Main Business
5.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Products, Services and Solutions
5.2.4 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue (US$ Million) & (2024-2024)
5.2.5 Passage Bio and Lysogene Recent Developments
6 North America
6.1 North America GM1 Gangliosidosis Treatment Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe GM1 Gangliosidosis Treatment Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America GM1 Gangliosidosis Treatment Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 GM1 Gangliosidosis Treatment Market Dynamics
11.1 GM1 Gangliosidosis Treatment Industry Trends
11.2 GM1 Gangliosidosis Treatment Market Drivers
11.3 GM1 Gangliosidosis Treatment Market Challenges
11.4 GM1 Gangliosidosis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market GM1 Gangliosidosis Treatment Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global GM1 Gangliosidosis Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global GM1 Gangliosidosis Treatment Market Size Share by Region (2024-2024)
Table 4. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global GM1 Gangliosidosis Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global GM1 Gangliosidosis Treatment Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global GM1 Gangliosidosis Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2024)
Table 9. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America GM1 Gangliosidosis Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America GM1 Gangliosidosis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe GM1 Gangliosidosis Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe GM1 Gangliosidosis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific GM1 Gangliosidosis Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific GM1 Gangliosidosis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America GM1 Gangliosidosis Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America GM1 Gangliosidosis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global GM1 Gangliosidosis Treatment Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global GM1 Gangliosidosis Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2024)
Table 24. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America GM1 Gangliosidosis Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America GM1 Gangliosidosis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe GM1 Gangliosidosis Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe GM1 Gangliosidosis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific GM1 Gangliosidosis Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific GM1 Gangliosidosis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America GM1 Gangliosidosis Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America GM1 Gangliosidosis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global GM1 Gangliosidosis Treatment Revenue (US$ Million) by Players (2024-2024)
Table 37. Global GM1 Gangliosidosis Treatment Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GM1 Gangliosidosis Treatment as of 2022)
Table 39. Date of Key Players Enter into GM1 Gangliosidosis Treatment Market
Table 40. Global GM1 Gangliosidosis Treatment Key Players Headquarters and Area Served
Table 41. GM1 Gangliosidosis Treatment Product Solution and Service
Table 42. Global GM1 Gangliosidosis Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Axovant Gene Therapies Ltd Basic Information List
Table 45. Axovant Gene Therapies Ltd Description and Business Overview
Table 46. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in GM1 Gangliosidosis Treatment Business of Axovant Gene Therapies Ltd (2024-2024)
Table 48. Axovant Gene Therapies Ltd Recent Developments
Table 49. Passage Bio and Lysogene Basic Information List
Table 50. Passage Bio and Lysogene Description and Business Overview
Table 51. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in GM1 Gangliosidosis Treatment Business of Passage Bio and Lysogene (2024-2024)
Table 53. Passage Bio and Lysogene Recent Developments
Table 54. North America GM1 Gangliosidosis Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 55. North America GM1 Gangliosidosis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 56. Europe GM1 Gangliosidosis Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 57. Europe GM1 Gangliosidosis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 58. Asia-Pacific GM1 Gangliosidosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 59. Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 60. Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 61. Asia-Pacific GM1 Gangliosidosis Treatment Market Share by Region (2024-2024)
Table 62. Asia-Pacific GM1 Gangliosidosis Treatment Market Share by Region (2024-2034)
Table 63. Latin America GM1 Gangliosidosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 64. Latin America GM1 Gangliosidosis Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 65. Latin America GM1 Gangliosidosis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 66. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 67. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 68. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 69. GM1 Gangliosidosis Treatment Market Trends
Table 70. GM1 Gangliosidosis Treatment Market Drivers
Table 71. GM1 Gangliosidosis Treatment Market Challenges
Table 72. GM1 Gangliosidosis Treatment Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GM1 Gangliosidosis Treatment Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global GM1 Gangliosidosis Treatment Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global GM1 Gangliosidosis Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global GM1 Gangliosidosis Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America GM1 Gangliosidosis Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe GM1 Gangliosidosis Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific GM1 Gangliosidosis Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America GM1 Gangliosidosis Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of LYS-GM101
Figure 11. Global LYS-GM101 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of PBGM01
Figure 13. Global PBGM01 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of AXO-AAV-GM1
Figure 15. Global AXO-AAV-GM1 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global GM1 Gangliosidosis Treatment Market Size Share by Type: 2022 & 2034
Figure 17. North America GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Figure 18. Europe GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Figure 20. Latin America GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa GM1 Gangliosidosis Treatment Revenue Market Share by Type (2024-2034)
Figure 22. Type 1 GM1 Gangliosidosis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Type 2 GM1 Gangliosidosis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Type 3 GM1 Gangliosidosis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global GM1 Gangliosidosis Treatment Market Size Share by Application: 2022 & 2034
Figure 26. North America GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Figure 27. Europe GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Figure 29. Latin America GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa GM1 Gangliosidosis Treatment Revenue Market Share by Application (2024-2034)
Figure 31. GM1 Gangliosidosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players GM1 Gangliosidosis Treatment Market Share in 2022
Figure 33. North America GM1 Gangliosidosis Treatment Market Share by Country (2024-2034)
Figure 34. United States GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 35. Canada GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 36. Germany GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 37. France GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 39. Italy GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 40. Russia GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific GM1 Gangliosidosis Treatment Market Share by Region (2024-2034)
Figure 43. China GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 44. Japan GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 47. India GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 48. Australia GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America GM1 Gangliosidosis Treatment Market Share by Country (2024-2034)
Figure 50. Mexico GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa GM1 Gangliosidosis Treatment Market Share by Country (2024-2034)
Figure 53. Turkey GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 55. UAE GM1 Gangliosidosis Treatment Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report